Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma

Antonino Carbone, Annunziata Gloghini, Carmelo Carlo-Stella

Blood (2023) 141 (18): 2187–2193.

https://doi.org/10.1182/blood.2022016590

Published: 2023

Journal Articles

Hematologic cancers in individuals infected by HIV

Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini

Blood (2022) 139 (7): 995–1012.

https://doi.org/10.1182/blood.2020005469

Published: 2022

Journal Articles

Simultaneous occurrence of KSHV-associated malignancies in a patient affected by HIV

Emanuela Vaccher, Antonino Carbone

Blood (2021) 137 (22): 3149.

https://doi.org/10.1182/blood.2021011649

Published: 2021

Journal Articles

Subclassifying peripheral T-cell lymphoma NOS

Antonino Carbone, Annunziata Gloghini

Blood (2019) 134 (24): 2120–2121.

https://doi.org/10.1182/blood.2019003385

Published: 2019

Journal Articles

Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?

Antonino Carbone, Annunziata Gloghini, Carmelo Carlo-Stella

Blood (2018) 132 (1): 17–22.

https://doi.org/10.1182/blood-2018-02-833806

Published: 2018

Journal Articles

A lymphomagenic role for HIV beyond immune suppression?

Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, Antonino Carbone

Blood (2016) 127 (11): 1403–1409.

https://doi.org/10.1182/blood-2015-11-681411

Published: 2016

Journal Articles

Activated DDR1 increases RS cell survival

Antonino Carbone, Annunziata Gloghini

Blood (2013) 122 (26): 4152–4154.

https://doi.org/10.1182/blood-2013-11-534123

Published: 2013

Journal Articles

The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies

Antonino Carbone, Annunziata Gloghini

Blood (2013) 122 (3): 459–460.

https://doi.org/10.1182/blood-2013-05-502799

Published: 2013

Journal Articles

How I treat: diagnosing and managing “in situ” lymphoma

Antonino Carbone, Armando Santoro

Blood (2011) 117 (15): 3954–3960.

https://doi.org/10.1182/blood-2010-10-299628

Published: 2011

Journal Articles

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

Blood (2011) 117 (8): 2405–2413.

https://doi.org/10.1182/blood-2010-07-296244

Published: 2011

Includes: Supplemental data

Journal Articles

Human CD34 + cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Cristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, Loredana Cleris, Marco Righi, Daniela Sia, Massimo Di Nicola, Michele Magni, Paolo Longoni, Marco Milanesi, Maura Francolini, Annunziata Gloghini, Antonino Carbone, Franca Formelli, Alessandro M. Gianni

Blood (2010) 115 (11): 2231–2240.

https://doi.org/10.1182/blood-2009-08-239632

Published: 2010

Includes: Supplemental data

Journal Articles

Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond

Donatella Aldinucci, Antonio Pinto, Annunziata Gloghini, Antonino Carbone

Blood (2010) 115 (3): 746–747.

https://doi.org/10.1182/blood-2009-10-247809

Published: 2010

Journal Articles

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Daniela Buglio, MD, Vidya Mamidipudi, Noor M Khaskhely, MD, PhD, Annunziata Gloghini, Antonino Carbone, MD, Carla Heise, Jeffrey M. Besterman, PhD, BSc, Robert E Martell, Kyle J MacBeth, Anas Younes, MD

Blood (2009) 114 (22): 3735.

https://doi.org/10.1182/blood.V114.22.3735.3735

Published: 2009

Journal Articles

HIV-associated lymphomas and gamma-herpesviruses

Antonino Carbone, Ethel Cesarman, Michele Spina, Annunziata Gloghini, Thomas F. Schulz

Blood (2009) 113 (6): 1213–1224.

https://doi.org/10.1182/blood-2008-09-180315

Published: 2009

Journal Articles

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

Carmelo Carlo-Stella, MD, Cristiana Lavazza, PhD, Arianna Giacomini, PhD, Loredana Cleris, Daniela Sia, PhD, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Massimo Di Nicola, MD, Annunziata Gloghini, PhD, Antonino Carbone, MD, Marco Righi, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD

Blood (2008) 112 (11): 2605.

https://doi.org/10.1182/blood.V112.11.2605.2605

Published: 2008

Journal Articles

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

Semra Aydin, Davide Rossi, Luciana Bergui, Giovanni D'Arena, Enza Ferrero, Lisa Bonello, Paola Omedé, Domenico Novero, Fortunato Morabito, Antonino Carbone, Gianluca Gaidano, Fabio Malavasi, Silvia Deaglio

Blood (2008) 111 (12): 5646–5653.

https://doi.org/10.1182/blood-2008-01-129726

Published: 2008

Journal Articles

Genome Wide-DNA Profiling of HIV-Related Non-Hodgkin Lymphomas: Implications for Disease Pathogenesis and Histogenesis.

Francesco Bertoni, MD, Giulia Poretti, Daniela Capello, Ivo Kwee, Clara Deambrogi, Annunziata Gloghini, Luigi Maria Larocca, Andrea Rinaldi, Davide Rossi, Emanuele Zucca, Antonino Carbone, Gianluca Gaidano

Blood (2007) 110 (11): 561.

https://doi.org/10.1182/blood.V110.11.561.561

Published: 2007

Journal Articles

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature.

Carmelo Carlo-Stella, MD, Cristiana Lavazza, Arianna Giacomini, Daniela Sia, Loredana Cleris, Massimo Di Nicola, M.D., Paolo Longoni, Marco Milanesi, Michele Magni, M.D., Marco Righi, M.D., Maura Francolini, Annunziata Gloghini, Anna Guidetti, M.D., Antonino Carbone, M.D., Alessandro M. Gianni, M.D.

Blood (2007) 110 (11): 527.

https://doi.org/10.1182/blood.V110.11.527.527

Published: 2007

Journal Articles

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL).

Carmelo Carlo-Stella, MD, Cristiana Lavazza, PhD, Massimo Di Nicola, MD, Loredana Cleris, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Daniele Morelli, MD, Annunziata Gloghini, MD, Antonino Carbone, MD, Alessandro M. Gianni, MD

Blood (2006) 108 (11): 233.

https://doi.org/10.1182/blood.V108.11.233.233

Published: 2006

Journal Articles

Interferon γ Enhances the Anti-Myeloma Activity of the Fully Human Anti-HLA-DR Monoclonal Antibody 1D09C3.

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Massimo Di Nicola, MD, Cristiana Lavazza, Loredana Cleris, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Zoltan Nagy, Paolo Corradini, MD, Antonino Carbone, MD, Franca Formelli, Alessandro M. Gianni, MD

Blood (2006) 108 (11): 656.

https://doi.org/10.1182/blood.V108.11.656.656

Published: 2006

NARROW

Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma

Hematologic cancers in individuals infected by HIV

Simultaneous occurrence of KSHV-associated malignancies in a patient affected by HIV

Subclassifying peripheral T-cell lymphoma NOS

Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?

A lymphomagenic role for HIV beyond immune suppression?

Activated DDR1 increases RS cell survival

The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies

How I treat: diagnosing and managing “in situ” lymphoma

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

Human CD34 + cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

HIV-associated lymphomas and gamma-herpesviruses

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

Genome Wide-DNA Profiling of HIV-Related Non-Hodgkin Lymphomas: Implications for Disease Pathogenesis and Histogenesis.

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature.

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL).

Interferon γ Enhances the Anti-Myeloma Activity of the Fully Human Anti-HLA-DR Monoclonal Antibody 1D09C3.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only